Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

1

US Approved Rx

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2015

1

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Concept

1

Protein

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA ORPHAN DRUG

2

CAS

1

ChEMBL

1

DRUG BANK

1

DRUG CENTRAL

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "ORPHAN DRUG|Designated/Approved|Treatment of von Willebrand disease." in comments (approximate match)

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

VONICOG ALFA

5PKM8P0G5I

Subunit 1 (2050) Similarity Search

Export Data
Sequence Search

Subunit 1 (2050) Similarity Search

Status:

US Approved Rx (2015)

First approved in 2015

Class:

PROTEIN

VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN)

5T6B772R4Q

Status:

Other

Class:

CONCEPT

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1